Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Golden

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 28, 2025
Microglial CLEC7A restrains amyloid beta plaque pathology in a mouse model of Alzheimer's diseaseAman Mangalmurti, Kristine E Zengeler, Ava Hollis, et al.
Oncogene|October 23, 2019
Precision medicine by designer interference peptides: applications in oncology and molecular therapeuticsAnabel Sorolla, Edina Wang, Emily Golden, et al.
Scientific Reports|January 19, 2017
An extended N-H bond, driven by a conserved second-order interaction, orients the flavin N5 orbital in cholesterol oxidaseEmily Golden, Li-Juan Yu, Flora Meilleur, et al.
The Biochemical Journal|February 5, 2013
Structure of a class III engineered cephalosporin acylase: comparisons with class I acylase and implications for differences in substrate specificity and catalytic activityEmily Golden, Rachel Paterson, Wan Jun Tie, et al.
Free Radical Research|January 7, 2020
Oxidation of cysteine 34 of plasma albumin as a biomarker of oxidative stressZi Xiang Lim, Marisa N Duong, Amber E Boyatzis, et al.
Learning & Memory (Cold Spring Harbor, N.Y.)|June 16, 2022
Darting across space and time: parametric modulators of sex-biased conditioned fear responsesJulia R Mitchell, Sean G Trettel, Anna J Li, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|May 6, 2019
Triple-hit therapeutic approach for triple negative breast cancers using docetaxel nanoparticles, EN1-iPeps and RGD peptidesAnabel Sorolla, Edina Wang, Tristan D Clemons, et al.
NPJ Precision Oncology|September 14, 2020
Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancerCiara Duffy, Anabel Sorolla, Edina Wang, et al.
Nature|December 10, 2020
Bidirectional perisomatic inhibitory plasticity of a Fos neuronal networkEe-Lynn Yap, Noah L Pettit, Christopher P Davis, et al.
Oncogene|August 5, 2018
Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancersEdina Wang, Anabel Sorolla, Paula T Cunningham, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 28, 2025
Microglial CLEC7A restrains amyloid beta plaque pathology in a mouse model of Alzheimer's diseaseAman Mangalmurti, Kristine E Zengeler, Ava Hollis, et al.
Oncogene|October 23, 2019
Precision medicine by designer interference peptides: applications in oncology and molecular therapeuticsAnabel Sorolla, Edina Wang, Emily Golden, et al.
Scientific Reports|January 19, 2017
An extended N-H bond, driven by a conserved second-order interaction, orients the flavin N5 orbital in cholesterol oxidaseEmily Golden, Li-Juan Yu, Flora Meilleur, et al.
The Biochemical Journal|February 5, 2013
Structure of a class III engineered cephalosporin acylase: comparisons with class I acylase and implications for differences in substrate specificity and catalytic activityEmily Golden, Rachel Paterson, Wan Jun Tie, et al.
Free Radical Research|January 7, 2020
Oxidation of cysteine 34 of plasma albumin as a biomarker of oxidative stressZi Xiang Lim, Marisa N Duong, Amber E Boyatzis, et al.
Learning & Memory (Cold Spring Harbor, N.Y.)|June 16, 2022
Darting across space and time: parametric modulators of sex-biased conditioned fear responsesJulia R Mitchell, Sean G Trettel, Anna J Li, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|May 6, 2019
Triple-hit therapeutic approach for triple negative breast cancers using docetaxel nanoparticles, EN1-iPeps and RGD peptidesAnabel Sorolla, Edina Wang, Tristan D Clemons, et al.
NPJ Precision Oncology|September 14, 2020
Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancerCiara Duffy, Anabel Sorolla, Edina Wang, et al.
Nature|December 10, 2020
Bidirectional perisomatic inhibitory plasticity of a Fos neuronal networkEe-Lynn Yap, Noah L Pettit, Christopher P Davis, et al.
Oncogene|August 5, 2018
Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancersEdina Wang, Anabel Sorolla, Paula T Cunningham, et al.
Pageof 3